BDNF and depressive symptom measurement: PGE2 has been demonstrated in inflammatory conditions to upregulate phosphodiesterase-4 (Oger et al. 2015), which in turn inhibits downstream formation of BDNF (Logan 2003), which itself is implicated in depression.